Jeffrey N. Simmons - 27 Feb 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
PRESIDENT, CEO AND DIRECTOR, Director
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons
Issuer symbol
ELAN
Transactions as of
27 Feb 2024
Net transactions value
-$1,062,114
Form type
4
Filing time
29 Feb 2024, 18:26:54 UTC
Previous filing
27 Feb 2024
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +148,084 +13% $0.000000 1,293,269 27 Feb 2024 Direct F1
transaction ELAN Common Stock Tax liability $1,062,114 -64,527 -5% $16.46 1,228,742 27 Feb 2024 Direct
holding ELAN Common Stock 45,000 27 Feb 2024 By Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,000 shares acquired on March 31, 2023, and 616 shares acquired on June 30, 2023, under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.